Loading...
XHEL
ORIOLA
Market cap160mUSD
Oct 30, Last price  
0.78EUR
1D
-1.52%
1Q
-13.04%
Jan 2017
-81.90%
IPO
-61.19%
Name

Oriola Oyj

Chart & performance

D1W1MN
XHEL:ORIOLA chart
P/E
—
P/S
0.09
EPS
—
Vol. 1Y
23.62%
Shs. 5Y
-0.01%
Rev. 5Y
-0.49%
Div Yld LY
8.97%
Div Yld TTM
3.85%
Revenues
1.68b
+12.44%
662,700,0001,377,300,0001,580,800,0001,713,100,0001,929,400,0002,146,000,0002,474,400,0002,598,500,0001,612,300,0001,626,300,0001,642,100,0001,527,700,0001,552,200,0001,721,300,0001,800,800,0001,882,400,0001,515,500,0001,493,800,0001,679,700,000
Net income
-20m
L-2.90%
9,600,00023,300,00027,500,00048,600,000102,100,000-24,100,00017,200,0005,800,000-212,300,00044,600,00042,800,00026,300,00012,700,0008,000,00011,300,00011,300,0004,800,000-20,700,000-20,100,000
CFO
39m
+303.13%
46,100,00039,000,000-18,100,000100,900,00088,700,00028,100,00046,100,00029,800,000-10,800,00085,600,00040,100,00023,700,000102,800,00084,400,00058,300,00040,000,00077,900,0009,600,00038,700,000
Dividend
Mar 26, 20260.03 EUR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Headquartered in Espoo, Finland, Oriola Oyj is a prominent provider of healthcare and wellbeing products and services across Sweden, Finland, and internationally. The company distributes a diverse range of items, including over-the-counter pharmaceuticals, general traded goods, vitamins, dietary supplements, cosmetics, skincare products, sports drinks, and wound care solutions. Beyond product supply, Oriola offers essential services such as logistics, advisory support, sales and marketing, and specialized expert assistance. These services cater to a broad clientele, encompassing pharmaceutical companies, pharmacies (including hospital pharmacies), veterinary practices, and grocery trade shops. Furthermore, the company provides pharmaceutical staffing and medication dose dispensing services for public and private healthcare operators, pharmacies, grocers, and other retailers. The company officially adopted the name Oriola Oyj in April 2017, having previously operated as Oriola-KD Oyj.

Related entities

Subsidiaries (2)
Kronans Apotek AB
Oriola Finland Oy

Key people

Non-Executive Independent Chairman of the Board · since 2023
Katarina Gabrielson
President, Chief Executive Officer, Member of the Executive Management Team · since 2022
Mats Danielsson
Chief Financial Officer, Member of the Executive Management Team · since 2024
Niklas Lindholm
Chief People Officer, Member of the Executive Management Team · since 2023
Maria Lundell
Chief People Officer, Member of the Executive Management Team · since 2025
Katja Lundell
Executive Vice President - Advisory Services, Member of the Executive Management Team · since 2025
Satu Nylen
Executive Vice President - Services and Products, Member of the Executive Management Team · since 2025
Stig Tornell
Executive Vice President - Sales, Member of the Executive Management Team · since 2025
Petter Sandstroem
General Counsel, Member of the Executive Management Team · since 2018
Mikael Nurmi
Chief Digital Officer, Member of the Executive Management Team · since 2023
Tuomas Tiilikainen
Chief Supply Chain Officer, Member of the Executive Management Team · since 2025
Harri Paerssinen
Non-Executive Independent Vice Chairman of the Board · since 2024
Non-Executive Independent Director · since 2024
Nina Maehoenen
Non-Executive Independent Director · since 2022
Ann Meyer
Non-Executive Independent Director · since 2024
Non-Executive Independent Director · since 2023
Non-Executive Independent Director · since 2023
IPO date
Jul 03, 2006
Employees
797
Domiciled in
FI
Incorporated in
FI
Headquarters & legal address
Orionintie 5
Espoo, 18 02200
FI
Previous name
Oriola-KD Oyj

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT